Lurbinectedin
Overview
Lurbinectedin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4297516).
API suppliers (8)
Suppliers of Lurbinectedin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 7 of 8 suppliers.
3 of 8 hold a GMP certificate on record in the EU or UK registers
- Wisdom Pharmaceutical Co., LtdChina1 active DMF
- Natco PharmaIndia1 active DMF GMP on record
- APICORE US LLCUnited States1 active DMF
- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO LTDChina1 active DMF
- XILING LAB CO LTDChina1 active DMF
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Chongqing Sintaho Pharmaceutical Co., Ltd.China1 active DMF
- PHARMA MAR SA1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Lurbinectedin expires 29 May 2040 and exclusivity 2 Oct 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(1R,2R,3R,11S,12S,14R,26R)-5,12-dihydroxy-6,6'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-22-yl] acetate
- Canonical SMILES
- CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O
- InChIKey
- YDDMIZRDDREKEP-HWTBNCOESA-N
Do you supply Lurbinectedin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.